Cargando…

Poor short-term glycemic control in patients with type 2 diabetes impairs the intestinal mucosal barrier: a prospective, single-center, observational study

BACKGROUND: To determine the relation between daily glycemic fluturation and the intestinal mucosal barrier dysfunction in type 2 diabetes mellitus (T2DM). METHODS: Totally 66 patients with T2DM were enrolled, 33 healthy volunteers were also recruited according to the enrolled patients’ gender and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Lijuan, Ao, Li, Xu, Haoben, Shi, Junfeng, You, Dali, Yu, Xiuwen, Xu, Weixin, Sun, Jie, Wang, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408809/
https://www.ncbi.nlm.nih.gov/pubmed/30849982
http://dx.doi.org/10.1186/s12902-019-0354-7
_version_ 1783401855450087424
author Shen, Lijuan
Ao, Li
Xu, Haoben
Shi, Junfeng
You, Dali
Yu, Xiuwen
Xu, Weixin
Sun, Jie
Wang, Fei
author_facet Shen, Lijuan
Ao, Li
Xu, Haoben
Shi, Junfeng
You, Dali
Yu, Xiuwen
Xu, Weixin
Sun, Jie
Wang, Fei
author_sort Shen, Lijuan
collection PubMed
description BACKGROUND: To determine the relation between daily glycemic fluturation and the intestinal mucosal barrier dysfunction in type 2 diabetes mellitus (T2DM). METHODS: Totally 66 patients with T2DM were enrolled, 33 healthy volunteers were also recruited according to the enrolled patients’ gender and age in a ratio of 2: 1. Patients were bisected by the median of endotoxins level into low(< 12.31 μ/l, n = 33) and high(≥12.31 μ/l, n = 33) blood endotoxin groups. Clinical data and blood glucose fluctuations were compared between groups. Multivariate regression analysis was used to determine the independent factors affecting the intestinal mucosal barrier. RESULTS: Serum endotoxin [12.1 (4.2~22.0) vs 3.2 (1.3~6.0), P < 0.001] and fasting blood glucose levels [9.8 ± 3.6 vs 5.4 ± 0.7, P < 0.001] were significantly higher in patients with T2DM than the control group. The standard deviation of blood glucose (SDBG) within 1 day [2.9 (2.0~3.3) vs. 2.1 (1.6~2.5), P = 0.012] and the largest amplitude of glycemic excursions (LAGE) [7.5 (5.4~8.9) vs. 5.9 (4.3~7.4), P = 0.034] were higher in the high endotoxin group than in the low endotoxin group. A multiple linear stepwise regression revealed a positive correlation between SDBG with endotoxin (standard partial regression coefficient = 0.255, P = 0.039). CONCLUSIONS: T2DM patients who incapable of maintaining stable blood glucose level are at a higher risk to associated with intestinal mucosal barrier injury.
format Online
Article
Text
id pubmed-6408809
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64088092019-03-21 Poor short-term glycemic control in patients with type 2 diabetes impairs the intestinal mucosal barrier: a prospective, single-center, observational study Shen, Lijuan Ao, Li Xu, Haoben Shi, Junfeng You, Dali Yu, Xiuwen Xu, Weixin Sun, Jie Wang, Fei BMC Endocr Disord Research Article BACKGROUND: To determine the relation between daily glycemic fluturation and the intestinal mucosal barrier dysfunction in type 2 diabetes mellitus (T2DM). METHODS: Totally 66 patients with T2DM were enrolled, 33 healthy volunteers were also recruited according to the enrolled patients’ gender and age in a ratio of 2: 1. Patients were bisected by the median of endotoxins level into low(< 12.31 μ/l, n = 33) and high(≥12.31 μ/l, n = 33) blood endotoxin groups. Clinical data and blood glucose fluctuations were compared between groups. Multivariate regression analysis was used to determine the independent factors affecting the intestinal mucosal barrier. RESULTS: Serum endotoxin [12.1 (4.2~22.0) vs 3.2 (1.3~6.0), P < 0.001] and fasting blood glucose levels [9.8 ± 3.6 vs 5.4 ± 0.7, P < 0.001] were significantly higher in patients with T2DM than the control group. The standard deviation of blood glucose (SDBG) within 1 day [2.9 (2.0~3.3) vs. 2.1 (1.6~2.5), P = 0.012] and the largest amplitude of glycemic excursions (LAGE) [7.5 (5.4~8.9) vs. 5.9 (4.3~7.4), P = 0.034] were higher in the high endotoxin group than in the low endotoxin group. A multiple linear stepwise regression revealed a positive correlation between SDBG with endotoxin (standard partial regression coefficient = 0.255, P = 0.039). CONCLUSIONS: T2DM patients who incapable of maintaining stable blood glucose level are at a higher risk to associated with intestinal mucosal barrier injury. BioMed Central 2019-03-08 /pmc/articles/PMC6408809/ /pubmed/30849982 http://dx.doi.org/10.1186/s12902-019-0354-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Shen, Lijuan
Ao, Li
Xu, Haoben
Shi, Junfeng
You, Dali
Yu, Xiuwen
Xu, Weixin
Sun, Jie
Wang, Fei
Poor short-term glycemic control in patients with type 2 diabetes impairs the intestinal mucosal barrier: a prospective, single-center, observational study
title Poor short-term glycemic control in patients with type 2 diabetes impairs the intestinal mucosal barrier: a prospective, single-center, observational study
title_full Poor short-term glycemic control in patients with type 2 diabetes impairs the intestinal mucosal barrier: a prospective, single-center, observational study
title_fullStr Poor short-term glycemic control in patients with type 2 diabetes impairs the intestinal mucosal barrier: a prospective, single-center, observational study
title_full_unstemmed Poor short-term glycemic control in patients with type 2 diabetes impairs the intestinal mucosal barrier: a prospective, single-center, observational study
title_short Poor short-term glycemic control in patients with type 2 diabetes impairs the intestinal mucosal barrier: a prospective, single-center, observational study
title_sort poor short-term glycemic control in patients with type 2 diabetes impairs the intestinal mucosal barrier: a prospective, single-center, observational study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408809/
https://www.ncbi.nlm.nih.gov/pubmed/30849982
http://dx.doi.org/10.1186/s12902-019-0354-7
work_keys_str_mv AT shenlijuan poorshorttermglycemiccontrolinpatientswithtype2diabetesimpairstheintestinalmucosalbarrieraprospectivesinglecenterobservationalstudy
AT aoli poorshorttermglycemiccontrolinpatientswithtype2diabetesimpairstheintestinalmucosalbarrieraprospectivesinglecenterobservationalstudy
AT xuhaoben poorshorttermglycemiccontrolinpatientswithtype2diabetesimpairstheintestinalmucosalbarrieraprospectivesinglecenterobservationalstudy
AT shijunfeng poorshorttermglycemiccontrolinpatientswithtype2diabetesimpairstheintestinalmucosalbarrieraprospectivesinglecenterobservationalstudy
AT youdali poorshorttermglycemiccontrolinpatientswithtype2diabetesimpairstheintestinalmucosalbarrieraprospectivesinglecenterobservationalstudy
AT yuxiuwen poorshorttermglycemiccontrolinpatientswithtype2diabetesimpairstheintestinalmucosalbarrieraprospectivesinglecenterobservationalstudy
AT xuweixin poorshorttermglycemiccontrolinpatientswithtype2diabetesimpairstheintestinalmucosalbarrieraprospectivesinglecenterobservationalstudy
AT sunjie poorshorttermglycemiccontrolinpatientswithtype2diabetesimpairstheintestinalmucosalbarrieraprospectivesinglecenterobservationalstudy
AT wangfei poorshorttermglycemiccontrolinpatientswithtype2diabetesimpairstheintestinalmucosalbarrieraprospectivesinglecenterobservationalstudy